Key statistics
As of last trade, Alterity Therapeutics Ltd (PBN0:FRA) traded at 2.58, 17.27% above the 52 week low of 2.20 set on Feb 04, 2026.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 2.84 |
|---|---|
| High | 2.86 |
| Low | 2.58 |
| Bid | 2.86 |
| Offer | 3.04 |
| Previous close | 2.86 |
| Average volume | 49.14 |
|---|---|
| Shares outstanding | 18.13m |
| Free float | 7.54m |
| P/E (TTM) | -- |
| Market cap | 61.89m USD |
| EPS (TTM) | -0.8749 USD |
Data delayed at least 15 minutes, as of Mar 02 2026 14:25 GMT.
More ▼
Announcements
- Alterity Therapeutics Recognizes Multiple System Atrophy (MSA) Awareness Month in March and the Urgent Need for Disease-Modifying Treatments
- Alterity Therapeutics: Appendix 4C – Q2 FY26 Quarterly Cash Flow Report & Corporate Update
- Alterity Therapeutics Issues Shareholder Letter Highlighting 2025 Progress and Key Objectives for 2026
- Alterity Therapeutics to Present at the Bell Potter Healthcare Virtual Conference
- Alterity Therapeutics Presents Promising Impact of ATH434 on Orthostatic Hypotension and Disease Progression in MSA at the 36th International Symposium on the Autonomic Nervous System
- Alterity Therapeutics: Appendix 4C – Q1 FY26 Quarterly Cash Flow Report
- Alterity Therapeutics Presents Positive Data from ATH434 Phase 2 Trial at the 2025 International Congress of Parkinson’s Disease and Movement Disorders
- Alterity Therapeutics to Deliver Multiple Presentations at the 2025 International Congress of Parkinson’s Disease and Movement Disorders
- Alterity Therapeutics Presents ATH434-201 Phase 2 Data at the American Neurological Association Annual Meeting
- Alterity Therapeutics Raises A$20.0 million in Strategic Placement
More ▼
